Evidence map›Paper›PMID 33123086›Full record

ReviewFrontiers in endocrinology2020

Siwen Zhang, Fei Li, Tong Zhou, Guixia Wang, Zhuo Li

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 110 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed, 1 pooled it
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 1 synthesis or guideline pooled it, 225 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. High-Throughput Toxicity Screening withEnvironmental science & technology · 2026
    Review
  11. Review
  12. Article
  13. Frontiers in aging neuroscience · 2026
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Siwen ZhangDepartment of Endocrinology and Metabolism, First Affiliated Hospital of Jilin University, Changchun, China.
Fei LiDepartment of Endocrinology and Metabolism, First Affiliated Hospital of Jilin University, Changchun, China.
Tong ZhouDepartment of Endocrinology and Metabolism, First Affiliated Hospital of Jilin University, Changchun, China.
Guixia WangDepartment of Endocrinology and Metabolism, First Affiliated Hospital of Jilin University, Changchun, China.
Zhuo LiDepartment of Endocrinology and Metabolism, First Affiliated Hospital of Jilin University, Changchun, China.
Jilin University · CNFirst Hospital of Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The

Indexed as

MutationAgingAMP-Activated Protein KinasesAnimalsCaenorhabditis elegansCaloric RestrictionDrug Evaluation, PreclinicalEpigenesis, GeneticInsulin-Like Growth Factor IModels, AnimalSignal TransductionTOR Serine-Threonine KinasesAMP-Activated Protein KinasesInsulin-Like Growth Factor ITOR Serine-Threonine KinasesAMPKdietary restrictiondrug screeningIGF-1mTOR

Identifiers

PMID33123086
PMCPMC7570440
OpenAlexW3090831677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.